"评价重组新型冠状病毒融合蛋白疫苗在健康人群免疫原性和安全性随机、双盲、安慰剂对照的II期临床试验". chictr.org.cn. Chinese Clinical Trial Registry. Retrieved 21 April 2021. "评价重组新型冠状病毒融合蛋白疫苗... 98 KB (20,593 words) - 02:58, 8 March 2024 |
"评价重组新型冠状病毒融合蛋白疫苗在健康人群免疫原性和安全性随机、双盲、安慰剂对照的II期临床试验". chictr.org.cn. Chinese Clinical Trial Registry. Retrieved 21 April 2021. "评价重组新型冠状病毒融合蛋白疫苗... 98 KB (20,593 words) - 02:58, 8 March 2024 |